Another most enjoyable webinar from our friends at the Prostate Cancer Foundation, this time focussing on the TheraP trial recently presented at #ASCO20, a randomised trial of Lu-PSMA vs cabazitaxel in progressive mCRPC. Professor Michael Hofman presents the data and is joined by an esteemed global panel including Professor Ian Davis, Professor Cora Sternberg and Professor Wolfgang Weber. Co-hosted by Professor Declan Murphy and Dr Howard Soule. More than 500 registrants from over 40 countries joined in, many of whom contributed to a very lively discussion. Enjoy!

Ver todos los episodios